PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424373
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424373
The global space medicine market size is expected to reach US$ 1,600 Mn by 2030, from US$ 770 Mn in 2023, at a CAGR of 11% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023/2024: | US$ 770 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 11.00% | 2030/2031 Value Projection: | US$ 1,600 Mn |
Space medicine is a relatively new field that aims to address the complex medical needs of human spaceflight. Some of the main products and areas of focus in space medicine include life support systems, space suits, and pharmaceuticals. Life support systems on spacecraft and space stations are designed to provide astronauts with breathable air, water, and protection from extreme temperatures and radiation exposure in space. Advanced space suits with integrated life support capabilities allow astronauts to perform extravehicular activities like spacewalks.
In terms of pharmaceuticals, new medications and medical equipment tailored to the space environment are being developed. Areas of research include drugs and technologies to prevent osteoporosis, address sensorimotor issues, treat psychological conditions like depression, and provide advanced surgical capabilities far from Earth. However, developing new medications for use in space also presents obstacles regarding safety testing and regulation in isolated conditions with limited resources. Overall, continued advancements in these diverse yet interconnected space medicine products will be crucial to enabling long-term human space exploration and colonization.
As more governments and private companies ramp up efforts to send humans into deeper space, the demand for specialized medical services and technologies tailored for spaceflight is growing rapidly. Key drivers fueling growth in the space medicine market include rising numbers of space tourists and commercial space stations in the low-earth orbit. An increasing volume of nanosatellites and orbital payload deliveries is also raising needs for monitoring astronaut health remotely. However, high costs associated with medical research in space poses a restraint. Growing international collaborations on the International Space Station presents opportunities to share costs and expertise. Advancements in biomedical engineering also promises more effective countermeasures against health risks like vision impairment, bone loss, and radiation exposure.